Generic Neurontin: Hurdles To TorPharm Approval Expected To Clear In Jan.
Executive Summary
Pfizer's Neurontin (gabapentin) could face generic competition as early as mid-January
You may also be interested in...
Purepac Gabapentin Is “First Generic” After Pfizer Delists Neurontin Patent
Purepac and Ivax will split "first generic" 180-day exclusivity on their versions of Pfizer's antiepileptic Neurontin (gabapentin)
Purepac Gabapentin Is “First Generic” After Pfizer Delists Neurontin Patent
Purepac and Ivax will split "first generic" 180-day exclusivity on their versions of Pfizer's antiepileptic Neurontin (gabapentin)
Neurontin Bulk Supply May Limit Generic Uptake, Pfizer Says
Neurontin generics will have to overcome limitations in the bulk drug supply in addition to Pfizer's patent defenses, Pfizer CEO Henry McKinnell told a Jan. 22 earnings conference call